Glioblastoma: Changing concepts in the WHO CNS5 classification

Keyphrases

• Area of Necrosis 12%
• Behavior Change 12%
• Central Nervous System 12%
• Central Nervous System Tumors 37%
• Clinical Symptoms 12%
• Copy number Variation 12%
• Dark Zone 12%
• Diffuse Astrocytoma 12%
• Epidermal Growth Factor Receptor Gene 12%
• Epithelioid Glioblastoma 12%
• Fifth Edition 12%
• Focal Neurological Deficit 12%
• Gene Amplification 12%
• Genetic Features 12%
• Genome Copy number 12%
• Giant Cell Glioblastoma 12%
• Glioblastoma 100%
• Gliosarcoma 12%
• Granular Cells 12%
• Headache 12%
• Histological Subtypes 12%
• Histopathological Features 12%
• Increased Intracranial Pressure 12%
• Isocitrate Dehydrogenase 1 (IDH1) 50%
• Microscopic Findings 12%
• Microvascular Proliferation 25%
• MRI Findings 12%
• Necrosis 12%
• Neurological Signs 12%
• Primitive Neuronal Component 12%
• Ring-enhancing Lesion 12%
• Seizure Behavior 12%
• Small Cell Glioblastoma 12%
• Telomerase Reverse Transcriptase Promoter mutation 12%
• Tumor Necrosis 12%
• WHO Classification of Tumours 12%
• WHO CNS5 100%
• WHO Grade 12%

Neuroscience

• Behavior Change 25%
• Central Nervous System 100%
• Chromosome 10 25%
• Epidermal Growth Factor Receptor 25%
• Gene Amplification 25%
• Headache 25%
• Isocitrate Dehydrogenase 100%
• Magnetic Resonance Imaging 25%
• Necrosis 75%
• Promoter Region 25%
• Receptor Gene 25%
• Telomerase Reverse Transcriptase 25%

Medicine and Dentistry

• Behavioral Change 9%
• Central Nervous System 18%
• Central Nervous System Tumor 18%
• Chromosome 10 9%
• Epidermal Growth Factor Receptor 9%
• Epileptic Seizure 9%
• Ganglioglioma 9%
• Gene Amplification 9%
• Glioblastoma 100%
• Gliosarcoma 9%
• Granular Cell 9%
• Headache 9%
• Intracranial Hypertension 9%
• Isocitrate Dehydrogenase 36%
• Magnetic Resonance Imaging 9%
• Necrosis 18%
• Neoplasm 9%
• Promoter Region 9%
• Receptor Gene 9%
• Ring-Enhancing Lesion 9%
• Symptom 9%
• Telomerase Reverse Transcriptase 9%
• Tumor Necrosis 9%